{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:31:31Z","timestamp":1792114291047,"version":"4.4.0"},"update-to":[{"DOI":"10.1002\/14651858.cd007667.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T00:00:00Z","timestamp":1599091200000}}],"reference-count":185,"publisher":"Wiley","issue":"9","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd007667.pub3","type":"journal-article","created":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T02:03:02Z","timestamp":1599098582000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Pharmacological interventions for antisocial personality disorder"],"prefix":"10.1002","volume":"2020","author":[{"given":"Najat R","family":"Khalifa","sequence":"additional","affiliation":[{"name":"Department of Psychiatry; Queen's University; Kingston Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Gibbon","sequence":"additional","affiliation":[{"name":"Arnold Lodge; Nottinghamshire Healthcare NHS Foundation Trust; Leicester UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit A","family":"V\u00f6llm","sequence":"additional","affiliation":[{"name":"Department of Forensic Psychiatry, Center for Neurology; University Rostock; Rostock Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie H-Y","family":"Cheung","sequence":"additional","affiliation":[{"name":"Forensic Research; Nottinghamshire Healthcare NHS Foundation Trust; Leicester UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"McCarthy","sequence":"additional","affiliation":[{"name":"Arnold Lodge; Nottinghamshire Healthcare NHS Foundation Trust; Leicester UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,9,3]]},"reference":[{"key":"10.1002\/14651858.CD007667.pub3-BIB0001|cit1","unstructured":"2010 review team Cochrane enquiry [personal communication] Email to: Arndt study team 2009"},{"issue":"11","key":"10.1002\/14651858.CD007667.pub3-BIB0002|cit2","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1001\/archpsyc.1992.01820110052008","article-title":"Desipramine treatment of cocaine dependence in methadone-maintained patients","volume":"49","author":"Arndt","year":"1992","journal-title":"Archives of General Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD007667.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/00005053-199403000-00004","article-title":"Desipramine treatment for cocaine dependence: role of antisocial personality disorder","volume":"182","author":"Arndt","year":"1994","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1002\/14651858.CD007667.pub3-BIB0004|cit4","doi-asserted-by":"crossref","unstructured":"Barratt ES Stanford MS Felthous AR Kent TA The effects of phenytoin on impulsive and premeditated aggression: a controlled study Journal of Clinical Psychopharmacology 1997 17 5 341 9 9315984","DOI":"10.1097\/00004714-199710000-00002"},{"issue":"10","key":"10.1002\/14651858.CD007667.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S0006-3223(96)00175-8","article-title":"Neuropsychological and cognitive psychophysiological substrates of impulsive aggression","volume":"41","author":"Barratt","year":"1997","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD007667.pub3-BIB0006|cit6","unstructured":"Coccaro E Cochrane review enquiry and request [personal communication] Email to: L McCarthy"},{"issue":"5","key":"10.1002\/14651858.CD007667.pub3-BIB0007|cit7","doi-asserted-by":"publisher","first-page":"653","DOI":"10.4088\/JCP.08m04150","article-title":"A double-blind, randomized, placebo-controlled trial of fluoxetine in patients with intermittent explosive disorder","volume":"70","author":"Coccaro","year":"2009","journal-title":"Journal of Clinical Psychiatry"},{"issue":"7","key":"10.1002\/14651858.CD007667.pub3-BIB0008|cit8","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1177\/0269881111408962","article-title":"Chronic tiagabine administration and aggressive responding in individuals with a history of substance abuse and antisocial behavior","volume":"26","author":"Gowin","year":"2012","journal-title":"Journal of Psychopharmacology"},{"issue":"6","key":"10.1002\/14651858.CD007667.pub3-BIB0009|cit9","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1038\/sj.npp.1300153","article-title":"Divalproex in the treatment of impulsive aggression: efficacy in cluster B personality disorders","volume":"28","author":"Hollander","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD007667.pub3-BIB0010|cit10","unstructured":"Cheung N Methylphenidate for attention deficit hyperactivity disorder and drug relapse in criminal offenders with substance dependence [personal communication] Email to: Konstenius M"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD007667.pub3-BIB0011|cit11","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.1017\/S1461145712000508","article-title":"ADHD in drug addiction: a RCT on the feasibility of methylphenidate treatment in criminal amphetamine users","volume":"15","author":"Franck","year":"2012","journal-title":"International Journal of Neuropsychopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD007667.pub3-BIB0012|cit12","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1111\/add.12369","article-title":"Methylphenidate for attention deficit hyperactivity disorder and drug relapse in criminal offenders with substance dependence: a 24-week randomized placebo-controlled trial","volume":"109","author":"Konstenius","year":"2014","journal-title":"Addiction"},{"issue":"1","key":"10.1002\/14651858.CD007667.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0376-8716(94)90107-4","article-title":"Antisocial personality disorder as a prognostic factor for pharmacotherapy of cocaine dependence","volume":"35","author":"Leal","year":"1994","journal-title":"Drug and Alcohol Dependence"},{"issue":"2","key":"10.1002\/14651858.CD007667.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1530-0277.1995.tb01532.x","article-title":"A double-blind, placebo-controlled study of nortriptyline and bromocriptine in male alcoholics subtyped by comorbid psychiatric disorders","volume":"19","author":"Powell","year":"1995","journal-title":"Alcoholism, Clinical and Experimental Research"},{"issue":"10","key":"10.1002\/14651858.CD007667.pub3-BIB0015|cit15","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/j.biopsych.2005.02.016","article-title":"Naltrexone and disulfiram in patients with alcohol dependence and comorbid psychiatric disorders","volume":"57","author":"Petrakis","year":"2005","journal-title":"Biological Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD007667.pub3-BIB0016|cit16","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1080\/10550490701643336","article-title":"The impact of personality disorders on alcohol-use outcomes in a pharmacotherapy trial for alcohol dependence and comorbid Axis I disorders","volume":"16","author":"Ralevski","year":"2007","journal-title":"American Journal on Addictions"},{"issue":"2-3","key":"10.1002\/14651858.CD007667.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0165-1781(01)00287-6","article-title":"A double-blind placebo-controlled crossover study of phenytoin in individuals with impulsive aggression","volume":"103","author":"Stanford","year":"2001","journal-title":"Psychiatry Research"},{"issue":"1","key":"10.1002\/14651858.CD007667.pub3-BIB0018|cit18","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1037\/1064-1297.13.1.72","article-title":"A comparison of anticonvulsants in the treatment of impulsive aggression","volume":"13","author":"Stanford","year":"2005","journal-title":"Experimental and Clinical Psychopharmacology"},{"issue":"6","key":"10.1002\/14651858.CD007667.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/00004714-200012000-00010","article-title":"Sertraline versus paroxetine in major depression: clinical outcome after six months of continuous therapy","volume":"20","author":"Aberg-Wistedt","year":"2000","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"1-3","key":"10.1002\/14651858.CD007667.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0165-0327(01)00393-7","article-title":"Comparison of the effects of fluoxetine, imipramine and placebo on personality in atypical depression","volume":"71","author":"Agosti","year":"2002","journal-title":"Journal of Affective Disorders"},{"issue":"4","key":"10.1002\/14651858.CD007667.pub3-BIB0021|cit21","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s40732-015-0139-y","article-title":"Effects of intranasal oxytocin on aggressive responding in antisocial personality disorder","volume":"65","author":"Rathnayaka","year":"2015","journal-title":"Psychological Record"},{"issue":"2","key":"10.1002\/14651858.CD007667.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1177\/000276427602000204","article-title":"Sociopathy: an experiment in internal environmental control","volume":"20","author":"Allen","year":"1976","journal-title":"American Behavioral Scientist"},{"issue":"3","key":"10.1002\/14651858.CD007667.pub3-BIB0023|cit23","first-page":"367","article-title":"A double-blind, placebo-controlled study of adjunctive nadolol in the management of violent psychiatric patients","volume":"26","author":"Alpert","year":"1990","journal-title":"Psychopharmacology Bulletin"},{"issue":"6","key":"10.1002\/14651858.CD007667.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/00004850-199911000-00007","article-title":"Structured diagnostic assessment and depot fluphenazine treatment of multiple suicide attempters in the emergency department","volume":"14","author":"Battaglia","year":"1999","journal-title":"International Clinical Psychopharmacology"},{"issue":"4","key":"10.1002\/14651858.CD007667.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0165-0327(94)90131-7","article-title":"Predictors of short-term treatment response in 66 patients with panic disorder","volume":"30","author":"Black","year":"1994","journal-title":"Journal of Affective Disorders"},{"issue":"12","key":"10.1002\/14651858.CD007667.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1001\/archpsyc.1997.01830240035005","article-title":"Fluoxetine and impulsive aggressive behaviour in personality-disordered subjects","volume":"54","author":"Coccaro","year":"1997","journal-title":"Archives of General Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD007667.pub3-BIB0027|cit27","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1097\/YIC.0b013e32834b80df","article-title":"The effects of sertraline on psychopathic traits","volume":"26","author":"Dunlop","year":"2011","journal-title":"International Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD007667.pub3-BIB0028|cit28","unstructured":"Garlow SJ Dunlop BW Neyman K Ninan PT Nemeroff CB The addition of tri-iodothyronine (T3) to sertraline does not enhance antidepressant response in patients with major depressive disorder Annual Meeting of the American College of Neuropsychopharmacology; 2007 Dec; Boca Raton (FL) 2007"},{"issue":"5","key":"10.1002\/14651858.CD007667.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/00004850-199809000-00003","article-title":"Personality disorder comorbidity with major depression and response to treatment with sertraline or citalopram","volume":"13","author":"Ekselius","year":"1998","journal-title":"International Clinical Psychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD007667.pub3-BIB0030|cit30","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1192\/bjp.bp.107.037234","article-title":"Antidepressant medications v. cognitive therapy in people with depression with or without personality disorder","volume":"192","author":"Fournier","year":"2008","journal-title":"British Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD007667.pub3-BIB0031|cit31","doi-asserted-by":"publisher","first-page":"60","DOI":"10.4088\/JCP.09m05256gry","article-title":"Fluoxetine treatment of alcoholic perpetrators of domestic violence: a 12-week, double-blind, randomized, placebo-controlled intervention study","volume":"72","author":"George","year":"2011","journal-title":"Journal of Clinical Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD007667.pub3-BIB0032|cit32","first-page":"544","article-title":"The effect of olanzapine and sertraline on personality disorder in patients with methadone maintenance therapy","volume":"22","author":"Jariani","year":"2010","journal-title":"Psychiatria Danubina"},{"issue":"2","key":"10.1002\/14651858.CD007667.pub3-BIB0033|cit33","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/ajad.12858","article-title":"Impulsiveness as a predictor of topiramate response for cocaine use disorder","volume":"28","author":"Blevins","year":"2019","journal-title":"American Journal on Addictions"},{"issue":"12","key":"10.1002\/14651858.CD007667.pub3-BIB0034|cit34","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1001\/jamapsychiatry.2013.2295","article-title":"Topiramate for the treatment of cocaine addiction: a randomized clinical trial","volume":"70","author":"Johnson","year":"2013","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD007667.pub3-BIB0035|cit35","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1053\/comp.2003.50001","article-title":"Borderline personality disorder in major depression: symptomatology, temperament, character, differential drug response, and 6-month outcome","volume":"44","author":"Joyce","year":"2003","journal-title":"Comprehensive Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD007667.pub3-BIB0036|cit36","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.drugalcdep.2013.05.026","article-title":"A double-blind, placebo-controlled trial of topiramate for the treatment of comorbid cocaine and alcohol dependence","volume":"133","author":"Kampman","year":"2013","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1002\/14651858.CD007667.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1521\/pedi.17.1.60.24058","article-title":"Changes in personality pathology after pharmacotherapy and combined therapy for depressed patients","volume":"17","author":"Kool","year":"2003b","journal-title":"Journal of Personality Disorders"},{"issue":"3","key":"10.1002\/14651858.CD007667.pub3-BIB0038|cit38","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1080\/10673220303950","article-title":"Efficacy of combined therapy and pharmacotherapy for depressed patients with or without personality disorders","volume":"11","author":"Kool","year":"2003a","journal-title":"Harvard Review of Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD007667.pub3-BIB0039|cit39","first-page":"361","article-title":"Treatment of depressive disorder and comorbid personality pathology: combined therapy versus pharmacotherapy","volume":"49","author":"Kool","year":"2007","journal-title":"Tijdschrift voor Psychiatrie"},{"issue":"2","key":"10.1002\/14651858.CD007667.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.pbb.2009.01.002","article-title":"Acute topiramate differentially affects human aggressive responding at low vs. moderate doses in subjects with histories of substance abuse and antisocial behavior","volume":"92","author":"Lane","year":"2009","journal-title":"Pharmacology, Biochemistry and Behavior"},{"issue":"2","key":"10.1002\/14651858.CD007667.pub3-BIB0041|cit41","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1176\/jnp.2.2.159","article-title":"Comparative effectiveness of carbamazepine and propranolol for rage outbursts","volume":"2","author":"Mattes","year":"1990","journal-title":"Journal of Neuropsychiatry and Clinical Neurosciences"},{"issue":"6","key":"10.1002\/14651858.CD007667.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/01.jcp.0000186739.22395.6b","article-title":"Oxcarbazepine in patients with impulsive aggression: a double-blind, placebo-controlled trial","volume":"25","author":"Mattes","year":"2005","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD007667.pub3-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"310","DOI":"10.4088\/JCP.v69n0218","article-title":"Levetiracetam in patients with impulsive aggression: a double-blind, placebo-controlled trial","volume":"69","author":"Mattes","year":"2008","journal-title":"Journal of Clinical Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD007667.pub3-BIB0044|cit44","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.biopsych.2004.11.044","article-title":"Treatment of aggression with topiramate in male borderline patients: a double-blind, placebo-controlled study","volume":"57","author":"Nickel","year":"2005","journal-title":"Biological Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD007667.pub3-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0010-440X(91)90076-O","article-title":"Personality traits associated with panic disorder: change associated with treatment","volume":"32","author":"Reich","year":"1991","journal-title":"Comprehensive Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD007667.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1192\/bjp.167.3.324","article-title":"The Edinburgh Primary Care Depression Study: personality disorder and outcome","volume":"167","author":"Patience","year":"1995","journal-title":"British Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD007667.pub3-BIB0047|cit47","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.euroneuro.2018.10.009","article-title":"Inhaled loxapine for agitation in patients with personality disorder: an initial approach","volume":"29","author":"Patrizi","year":"2019","journal-title":"European Neuropsychopharmacology"},{"issue":"6","key":"10.1002\/14651858.CD007667.pub3-BIB0048|cit48","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1176\/ajp.147.6.711","article-title":"Personality disorders and treatment outcome in the NIMH Treatment of Depression Collaborative Research Program","volume":"147","author":"Shea","year":"1990","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD007667.pub3-BIB0049|cit49","unstructured":"Surekha P Govil S Efficacy of lithium as anti-aggression agent in patients with antisocial personality disorder 65th Annual National Conference of the Indian Psychiatric Society; 2013 Jan 10-13; Bangalore (IN) 2013 S71 2"},{"key":"10.1002\/14651858.CD007667.pub3-BIB0050|cit50","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.psyneuen.2017.07.483","article-title":"Oxytocin improves facial emotion recognition in young adults with antisocial personality disorder","volume":"85","author":"Timmermann","year":"2017","journal-title":"Psychoneuroendocrinology"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD007667.pub3-BIB0051|cit51","doi-asserted-by":"publisher","first-page":"S231","DOI":"10.1016\/S0924-977X(12)70342-5","article-title":"Mood stabilisers in the treatment of personality disorders and comorbid depression","volume":"22","author":"Todorovic","year":"2012","journal-title":"European Neuropsychopharmacology"},{"issue":"9","key":"10.1002\/14651858.CD007667.pub3-BIB0052|cit52","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1111\/acer.12802","article-title":"Poorer drinking outcomes with citalopram treatment for alcohol dependence: a randomized, double-blind, placebo-controlled trial","volume":"39","author":"Charney","year":"2015","journal-title":"Alcoholism: Clinical and Experimental Research"},{"key":"10.1002\/14651858.CD007667.pub3-BIB0053|cit53","unstructured":"Gill K Poorer drinking outcomes with citalopram treatment for alcohol dependence: a randomized, double-blind, placebo-controlled trial [personal communication] Email to: N Cheung"},{"key":"10.1002\/14651858.CD007667.pub3-BIB0054|cit54","unstructured":"2010 review team Cochrane enquiry [personal communication] Email to: D Hellerstein 2010"},{"issue":"9","key":"10.1002\/14651858.CD007667.pub3-BIB0055|cit55","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1176\/appi.ajp.157.9.1436","article-title":"Double-blind comparison of sertraline, imipramine, and placebo in the treatment of dysthymia: effects on personality","volume":"157","author":"Hellerstein","year":"2000","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD007667.pub3-BIB0056|cit56","unstructured":"2010 review team Cochrane enquiry [personal communication] Email to: R Verkes 2010"},{"issue":"4","key":"10.1002\/14651858.CD007667.pub3-BIB0057|cit57","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1176\/ajp.155.4.543","article-title":"Reduction by paroxetine of suicidal behavior in patients with repeated suicide attempts but not major depression","volume":"155","author":"Verkes","year":"1998","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD007667.pub3-BIB0058|cit58","unstructured":"Oxytocin effects in autistic and antisocial male adults www.clinicaltrialsregister.eu\/ctr-search\/trial\/2010-018740-13\/NL#A"},{"issue":"3","key":"10.1002\/14651858.CD007667.pub3-BIB0059|cit59","doi-asserted-by":"publisher","first-page":"214-22","DOI":"10.1037\/a0031681","article-title":"Sex differences in antisocial personality disorder: results from the National Epidemiological Survey on Alcohol and Related Conditions","volume":"4","author":"Alegria","year":"2013","journal-title":"Personality Disorders"},{"issue":"7066","key":"10.1002\/14651858.CD007667.pub3-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/bmj.313.7066.1200","article-title":"Detecting skewness from summary information","volume":"313","author":"Altman","year":"1996","journal-title":"BMJ"},{"issue":"11","key":"10.1002\/14651858.CD007667.pub3-BIB0061|cit61","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1001\/archpsyc.1992.01820110052008","article-title":"Desipramine treatment of cocaine dependence in methadone-maintained patients","volume":"49","author":"Arndt","year":"1992","journal-title":"Archives of General Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD007667.pub3-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0149-7189(82)90074-X","article-title":"The Client Satisfaction Questionnaire. Psychometric properties and correlations with service utilization and psychotherapy outcome","volume":"5","author":"Attkisson","year":"1982","journal-title":"Evaluation and Program Planning"},{"issue":"2","key":"10.1002\/14651858.CD007667.pub3-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1037\/0022-006X.69.2.184","article-title":"Service profiling and outcomes benchmarking using the CORE-OM: toward practice-based evidence in the psychological therapies","volume":"69","author":"Barkham","year":"2001","journal-title":"Journal of Consulting and Clinical Psychology"},{"issue":"6","key":"10.1002\/14651858.CD007667.pub3-BIB0064|cit64","doi-asserted-by":"publisher","first-page":"388-9","DOI":"10.1097\/00004714-199112000-00017","article-title":"A controlled trial of phenytoin in impulsive aggression","volume":"11","author":"Barratt","year":"1991","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"10","key":"10.1002\/14651858.CD007667.pub3-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S0006-3223(96)00175-8","article-title":"Neuropsychological and cognitive psychophysiological substrates of impulsive aggression","volume":"41","author":"Barratt","year":"1997","journal-title":"Biological Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD007667.pub3-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1037\/0022-006X.56.6.893","article-title":"An inventory for measuring clinical anxiety: psychometric properties","volume":"56","author":"Beck","year":"1988","journal-title":"Journal of Consulting and Clinical Psychology"},{"issue":"2","key":"10.1002\/14651858.CD007667.pub3-BIB0067|cit67","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0033-3182(96)71579-7","article-title":"Death rates in 71 men with antisocial personality disorder: a comparison with general population mortality","volume":"37","author":"Black","year":"1996","journal-title":"Psychosomatics"},{"key":"10.1002\/14651858.CD007667.pub3-BIB0068|cit68","volume-title":"Bad Boys, Bad Men: Confronting Antisocial Personality Disorder","author":"Black","year":"1999"},{"issue":"2","key":"10.1002\/14651858.CD007667.pub3-BIB0069|cit69","first-page":"113","article-title":"Antisocial personality disorder in incarcerated offenders: psychiatric comorbidity and quality of life","volume":"22","author":"Black","year":"2010","journal-title":"Annals of Clinical Psychiatry"},{"issue":"7","key":"10.1002\/14651858.CD007667.pub3-BIB0070|cit70","doi-asserted-by":"publisher","first-page":"309-14","DOI":"10.1177\/070674371506000703","article-title":"The natural history of antisocial personality disorder","volume":"60","author":"Black","year":"2015","journal-title":"Canadian Journal of Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD007667.pub3-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1136\/jnnp.71.6.727","article-title":"Neurocognitive models of aggression, the antisocial personality disorders, and psychopathy","volume":"71","author":"Blair","year":"2001","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"1-3","key":"10.1002\/14651858.CD007667.pub3-BIB0072|cit72","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.ejphar.2005.09.067","article-title":"Antidepressant treatments and human aggression","volume":"526","author":"Bond","year":"2005","journal-title":"European Journal of Pharmacology"},{"key":"10.1002\/14651858.CD007667.pub3-BIB0073|cit73","volume-title":"British National Formulary","author":"Joint Formulary Committee","year":"2018"},{"issue":"3","key":"10.1002\/14651858.CD007667.pub3-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1037\/0022-3514.63.3.452","article-title":"The Aggression Questionnaire","volume":"63","author":"Buss","year":"1992","journal-title":"Journal of Personality and Social Psychology"},{"issue":"1","key":"10.1002\/14651858.CD007667.pub3-BIB0075|cit75","first-page":"16","article-title":"An update on the Dissociative Experiences Scale","volume":"6","author":"Carlson","year":"1993","journal-title":"Dissociation: Progress in the Dissociative Disorders"},{"issue":"1","key":"10.1002\/14651858.CD007667.pub3-BIB0076|cit76","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1037\/0022-006X.66.1.7","article-title":"Defining empirically supported therapies","volume":"66","author":"Chambless","year":"1998","journal-title":"Journal of Consulting and Clinical Psychology"},{"issue":"6","key":"10.1002\/14651858.CD007667.pub3-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1001\/archpsyc.1996.01830060075010","article-title":"Impulsive aggression in personality disorder correlates with tritiated paroxetine binding in the platelet","volume":"53","author":"Coccaro","year":"1996","journal-title":"Archives of General Psychiatry"},{"issue":"8","key":"10.1002\/14651858.CD007667.pub3-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1001\/archpsyc.55.8.708","article-title":"Cerebrospinal fluid vasopressin levels: correlates with aggression and serotonin function in personality-disordered subjects","volume":"55","author":"Coccaro","year":"1998","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD007667.pub3-BIB0079|cit79","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1192\/bjp.188.5.423","article-title":"Prevalence and correlates of personality disorder in Great Britain","volume":"188","author":"Coid","year":"2006","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD007667.pub3-BIB0080|cit80","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ijlp.2015.01.009","article-title":"Psychiatric diagnosis and differential risks of offending following discharge","volume":"38","author":"Coid","year":"2015","journal-title":"International Journal of Law and Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD007667.pub3-BIB0081|cit81","doi-asserted-by":"publisher","first-page":"677","DOI":"10.4088\/JCP.v66n0602","article-title":"Prevalence, correlates, and comorbidity of DSM-IV antisocial personality syndromes and alcohol and specific drug use disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions","volume":"66","author":"Compton","year":"2005","journal-title":"Journal of Clinical Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD007667.pub3-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1001\/archpsyc.1988.01800260015002","article-title":"Pharmacotherapy of borderline personality disorder: alprazolam, carbamazepine, trifluoperazine and tranylcypromine","volume":"45","author":"Cowdry","year":"1988","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD007667.pub3-BIB0083|cit83","unstructured":"Crawford M Rutter D Price K Weaver T Josson M Tyrer P Learning the lessons: a multi-method evaluation of dedicated community-based services for people with personality disorder www.netscc.ac.uk\/hsdr\/files\/project\/SDO_FR_08-1404-083_V01.pdf"},{"issue":"8","key":"10.1002\/14651858.CD007667.pub3-BIB0084|cit84","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.jclinepi.2013.03.009","article-title":"Combining follow-up and change data is valid in meta-analyses of continuous outcomes: meta-epidemiological study","volume":"66","author":"Da Costa","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD007667.pub3-BIB0085|cit85","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1192\/bjp.bp.106.029215","article-title":"Long-term outcomes after discharge from medium secure care: a cause for concern","volume":"191","author":"Davies","year":"2007","journal-title":"British Journal of Psychiatry"},{"issue":"Suppl","key":"10.1002\/14651858.CD007667.pub3-BIB0086|cit86","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/978-3-7091-6020-6_5","article-title":"Depression and antisocial personality disorder: two contrasting disorders of 5HT function","volume":"64","author":"Deakin","year":"2003","journal-title":"Journal of Neural Transmission"},{"issue":"1","key":"10.1002\/14651858.CD007667.pub3-BIB0087|cit87","first-page":"13","article-title":"SCL-90: an outpatient psychiatric rating scale--preliminary report","volume":"9","author":"Derrogatis","year":"1973","journal-title":"Psychopharmacology Bulletin"},{"issue":"2-3","key":"10.1002\/14651858.CD007667.pub3-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0165-1781(00)00224-9","article-title":"Neurocognitive function in antisocial personality disorder","volume":"97","author":"Dinn","year":"2000","journal-title":"Psychiatry Research"},{"key":"10.1002\/14651858.CD007667.pub3-BIB0089|cit89","volume-title":"Psychopathic and Anti-Social Personality Disorders: Treatment and Research Issues","author":"Dolan","year":"1993"},{"issue":"1","key":"10.1002\/14651858.CD007667.pub3-BIB0090|cit90","first-page":"2","article-title":"Antisocial personality disorder and psychopathy in women: A literature review on the reliability and validity of assessment instruments","volume":"32","year":"2009","journal-title":"Women and Criminality"},{"issue":"5","key":"10.1002\/14651858.CD007667.pub3-BIB0091|cit91","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1177\/096228020101000502","article-title":"Statistical methods for the meta-analysis of cluster randomization trials","volume":"10","author":"Donner","year":"2001","journal-title":"Statistical Methods in Medical Research"},{"key":"10.1002\/14651858.CD007667.pub3-BIB0092|cit92","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-5)","author":"American Psychiatric Association","year":"2013"},{"key":"10.1002\/14651858.CD007667.pub3-BIB0093|cit93","volume-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)","author":"American Psychiatric Association","year":"1994"},{"key":"10.1002\/14651858.CD007667.pub3-BIB0094|cit94","volume-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR)","author":"American Psychiatric Association","year":"2000"},{"issue":"3","key":"10.1002\/14651858.CD007667.pub3-BIB0095|cit95","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1002\/pmh.41","article-title":"The use of pharmacological treatments for people with personality disorder: a systematic review of randomized controlled trials","volume":"2","author":"Duggan","year":"2008","journal-title":"Personality and Mental Health"},{"issue":"5","key":"10.1002\/14651858.CD007667.pub3-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1192\/bjp.164.5.630","article-title":"South Westminster Schizophrenia Survey. Alcohol use and its relationship to symptoms, tardive dyskinesia and illness onset","volume":"164","author":"Duke","year":"1994","journal-title":"British Journal of Psychiatry"},{"issue":"7109","key":"10.1002\/14651858.CD007667.pub3-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD007667.pub3-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"issue":"3","key":"10.1002\/14651858.CD007667.pub3-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","article-title":"EuroQoL: a new facility for the measurement of health-related quality of life","volume":"16","author":"EuroQoL Group","year":"1990","journal-title":"Health Policy"},{"issue":"9306","key":"10.1002\/14651858.CD007667.pub3-BIB0100|cit100","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/S0140-6736(02)07740-1","article-title":"Serious mental disorder in 23000 prisoners: a systematic review of 62 surveys","volume":"359","author":"Fazel","year":"2002","journal-title":"Lancet"},{"issue":"7","key":"10.1002\/14651858.CD007667.pub3-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/0895-4356(92)90054-Q","article-title":"Variance imputation for overviews of clinical trials with continuous response","volume":"45","author":"Follmann","year":"1992","journal-title":"Journal of Clinical Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD007667.pub3-BIB0102|cit102","doi-asserted-by":"publisher","first-page":"57-66","DOI":"10.1016\/j.janxdis.2013.11.009","article-title":"Comorbidity of social anxiety disorder and antisocial personality disorder in the National Epidemiological Survey on Alcohol and Related Conditions (NESARC)","volume":"28","author":"Galbraith","year":"2014","journal-title":"Journal of Anxiety Disorders"},{"issue":"6","key":"10.1002\/14651858.CD007667.pub3-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.jclinepi.2004.09.013","article-title":"Uncertainty method improved on best-worst case analysis in a binary meta-analysis","volume":"58","author":"Gamble","year":"2005","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD007667.pub3-BIB0104|cit104","unstructured":"Garlow SJ Dunlop BW Neyman K Ninan PT Nemeroff CB The addition of tri-iodothyronine (T3) to sertraline does not enhance antidepressant response in patients with major depressive disorder 46th Annual Meeting of the American College of Neuropsychopharmacology; 2007 Dec 9-13; Boca Raton (FL) 2007"},{"issue":"2","key":"10.1002\/14651858.CD007667.pub3-BIB0105|cit105","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S0165-1781(02)00320-7","article-title":"Lifetime comorbidity of antisocial personality disorder and anxiety disorders among adults in the community","volume":"117","author":"Goodwin","year":"2003","journal-title":"Psychiatry Research"},{"issue":"6","key":"10.1002\/14651858.CD007667.pub3-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/0010-440X(73)90036-9","article-title":"Effects of diphenylhydantoin on anxiety and hostility in institutionalized prisoners","volume":"14","author":"Gottschalk","year":"1973","journal-title":"Comprehensive Psychiatry"},{"key":"10.1002\/14651858.CD007667.pub3-BIB0107|cit107","unstructured":"McMaster University (developed by Evidence Prime) GRADEpro GDT 2015"},{"issue":"2","key":"10.1002\/14651858.CD007667.pub3-BIB0108|cit108","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1097\/00131746-199803000-00001","article-title":"Course and stability of personality disorders","volume":"4","author":"Grilo","year":"1998","journal-title":"Journal of Practical Psychiatry and Behavioural Health"},{"issue":"3","key":"10.1002\/14651858.CD007667.pub3-BIB0109|cit109","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1002\/pmh.1415","article-title":"The prevalence of comorbid alcohol use disorder in the presence of personality disorder: systematic review and explanatory modelling","volume":"12","author":"Guy","year":"2018","journal-title":"Personality and Mental Health"},{"issue":"4","key":"10.1002\/14651858.CD007667.pub3-BIB0110|cit110","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.jclinepi.2010.07.017","article-title":"GRADE guidelines: 4. Rating the quality of evidence--study limitations (risk of bias)","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"3","key":"10.1002\/14651858.CD007667.pub3-BIB0111|cit111","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1177\/1740774508091600","article-title":"Imputation methods for missing outcome data in meta-analysis of clinical trials","volume":"5","author":"Higgins","year":"2008","journal-title":"Clinical Trials"},{"key":"10.1002\/14651858.CD007667.pub3-BIB0112|cit112","unstructured":"Higgins JP Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD007667.pub3-BIB0113|cit113","unstructured":"Higgins JPT Altman DG Sterne JAC Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD007667.pub3-BIB0114|cit114","unstructured":"Higgins JPT Thomas J Chandler J Cumpston M Li T Page MJ Cochrane Handbook for Systematic Reviews of Interventions version 6.0 www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD007667.pub3-BIB0115|cit115","unstructured":"Home Office Department of Health Managing Dangerous People with Severe Personality Disorder: Proposals for Policy Development; July 1999 webarchive.nationalarchives.gov.uk\/+\/http:\/www.homeoffice.gov.uk\/documents\/cons-1999-personality-disorder?view=Binary 1999"},{"issue":"2","key":"10.1002\/14651858.CD007667.pub3-BIB0116|cit116","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003499.pub3","article-title":"Antiepileptics for aggression and associated impulsivity","author":"Huband","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD007667.pub3-BIB0117|cit117","volume-title":"The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines","author":"World Health Organization (WHO)","year":"1992"},{"key":"10.1002\/14651858.CD007667.pub3-BIB0118|cit118","unstructured":"World Health Organization ICD-11: International Classification of Diseases for Mortality and Morbidity Statistics 11th Revision www.who.int\/classifications\/icd\/en"},{"key":"10.1002\/14651858.CD007667.pub3-BIB0119|cit119","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/1471-2288-14-120","article-title":"Thresholds for statistical and clinical significance in systematic reviews with meta-analytic methods","volume":"14","author":"Jakobsen","year":"2014","journal-title":"BMC Medical Research Methodology"},{"key":"10.1002\/14651858.CD007667.pub3-BIB0120|cit120","volume-title":"The Power Threat Meaning Framework: Towards the identification of patterns in emotional distress, unusual experiences and troubled or troubling behaviour, as an alternative to functional psychiatric diagnosis","author":"Johnstone","year":"2018"},{"issue":"5","key":"10.1002\/14651858.CD007667.pub3-BIB0121|cit121","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s00127-018-1628-5","article-title":"Antisocial personality and risks of cause-specific mortality: results from the Epidemiologic Catchment Area study with 27\u00a0years of follow-up","volume":"54","author":"Krasnova","year":"2019","journal-title":"Social Psychiatry and Psychiatric Epidemiology"},{"key":"10.1002\/14651858.CD007667.pub3-BIB0122|cit122","doi-asserted-by":"crossref","unstructured":"Lefebvre C Glanville J Briscoe S Littlewood A Marshall C Chapter 4: Searching for and selecting studies. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane, 2019. Available from www.training.cochrane.org\/handbook","DOI":"10.1002\/9781119536604.ch4"},{"issue":"1","key":"10.1002\/14651858.CD007667.pub3-BIB0123|cit123","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1192\/bjp.bp.108.062984","article-title":"Pharmacotherapy for borderline personality disorder: Cochrane systematic review of randomised trials","volume":"196","author":"Lieb","year":"2010","journal-title":"British Journal of Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD007667.pub3-BIB0124|cit124","doi-asserted-by":"publisher","first-page":"e010606","DOI":"10.1136\/bmjopen-2015-010606","article-title":"Conflicts of interest and spin in reviews of psychological therapies: a systematic review","volume":"6","author":"Lieb","year":"2016","journal-title":"BMJ Open"},{"issue":"2","key":"10.1002\/14651858.CD007667.pub3-BIB0125|cit125","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1521\/pedi.1990.4.2.173","article-title":"Lithium therapy for borderline patients: preliminary findings","volume":"4","author":"Links","year":"1990","journal-title":"Journal of Personality Disorders"},{"issue":"2","key":"10.1002\/14651858.CD007667.pub3-BIB0126|cit126","first-page":"70-1","article-title":"Benzodiazepines in the treatment of aggressive patients","volume":"40","author":"Lion","year":"1979","journal-title":"Journal of Clinical Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD007667.pub3-BIB0127|cit127","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1521\/pedi.2007.21.2.199","article-title":"A framework for integrating dimensional and categorical classifications of personality disorder","volume":"21","author":"Livesley","year":"2007","journal-title":"Journal of Personality Disorders"},{"issue":"2","key":"10.1002\/14651858.CD007667.pub3-BIB0128|cit128","first-page":"215","article-title":"The Overt Aggression Scale in the study of lithium in aggressive conduct disorder","volume":"30","author":"Malone","year":"1994","journal-title":"Psychopharmacology Bulletin"},{"issue":"1","key":"10.1002\/14651858.CD007667.pub3-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1521\/pedi.18.1.90.32768","article-title":"Recent trends in the pharmacotherapy of personality disorders","volume":"18","author":"Markovitz","year":"2004","journal-title":"Journal of Personality Disorders"},{"issue":"4","key":"10.1002\/14651858.CD007667.pub3-BIB0130|cit130","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1177\/0306624X00444002","article-title":"Antisocial and psychopathic personality disorders: causes, course, and remission - a review article","volume":"44","author":"Martens","year":"2000","journal-title":"International Journal of Offender Therapy and Comparative Criminology"},{"issue":"3","key":"10.1002\/14651858.CD007667.pub3-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1017\/S0140525X98001228","article-title":"Testosterone and dominance in men","volume":"21","author":"Mazur","year":"1998","journal-title":"Behavioral and Brain Sciences"},{"key":"10.1002\/14651858.CD007667.pub3-BIB0132|cit132","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-244X-10-33","article-title":"A systematic review of personality disorder, race and ethnicity: prevalence, aetiology and treatment","volume":"10","author":"McGilloway","year":"2010","journal-title":"BMC Psychiatry"},{"issue":"18","key":"10.1002\/14651858.CD007667.pub3-BIB0133|cit133","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1001\/jama.279.18.1489","article-title":"CONSORT: an evolving tool to help improve the quality of reports of randomized controlled trials. Consolidated Standards of Reporting Trials","volume":"279","author":"Moher","year":"1998","journal-title":"JAMA"},{"issue":"7","key":"10.1002\/14651858.CD007667.pub3-BIB0134|cit134","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Medicine"},{"key":"10.1002\/14651858.CD007667.pub3-BIB0135|cit135","doi-asserted-by":"publisher","first-page":"c869","DOI":"10.1136\/bmj.c869","article-title":"CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Moher","year":"2010","journal-title":"BMJ"},{"issue":"5","key":"10.1002\/14651858.CD007667.pub3-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s001270050138","article-title":"The epidemiology of antisocial personality disorder","volume":"34","author":"Moran","year":"1999","journal-title":"Social Psychiatry and Psychiatric Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD007667.pub3-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0006-3223(90)90660-T","article-title":"Serotonergic responsivity and behavioral dimensions in antisocial personality disorder with substance abuse","volume":"28","author":"Moss","year":"1990","journal-title":"Biological Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD007667.pub3-BIB0138|cit138","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1176\/ajp.155.4.479","article-title":"Progression from conduct disorder to antisocial personality disorder following treatment for adolescent substance abuse","volume":"155","author":"Myers","year":"1998","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD007667.pub3-BIB0139|cit139","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1093\/biomet\/31.1-2.20","article-title":"The distribution of range in samples from a normal population, expressed in terms of an independent estimate of standard deviation","volume":"31","author":"Newman","year":"1939","journal-title":"Biometrika"},{"key":"10.1002\/14651858.CD007667.pub3-BIB0140|cit140","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1192\/bjp.188.1.13","article-title":"Personality disorder and the outcome of depression: meta-analysis of published studies","volume":"188","author":"Newton-Howes","year":"2006","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD007667.pub3-BIB0141|cit141","unstructured":"National Institute for Health and Care Excellence Antisocial personality disorder: prevention and management www.nice.org.uk\/guidance\/cg77\/evidence\/full-guideline-242104429"},{"key":"10.1002\/14651858.CD007667.pub3-BIB0142|cit142","unstructured":"National Institute for Health and Care Excellence Personality disorders: borderline and antisocial; 11 June 2015 www.nice.org.uk\/guidance\/qs88 2015"},{"issue":"6-7","key":"10.1002\/14651858.CD007667.pub3-BIB0143|cit143","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1080\/j.1440-1614.2006.01834.x","article-title":"Psychopathy\/antisocial personality disorder conundrum","volume":"40","author":"Ogloff","year":"2006","journal-title":"Australian & New Zealand Journal of Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD007667.pub3-BIB0144|cit144","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1037\/pas0000693","article-title":"Evaluating the assessment of the ICD-11 personality disorder diagnostic system","volume":"31","author":"Oltmanns","year":"2019","journal-title":"Psychological Assessment"},{"key":"10.1002\/14651858.CD007667.pub3-BIB0145|cit145","volume-title":"Social Trends 34","author":"Office for National Statistics","year":"2004"},{"key":"10.1002\/14651858.CD007667.pub3-BIB0146|cit146","doi-asserted-by":"publisher","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The Brief Psychiatric Rating Scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychological Reports"},{"key":"10.1002\/14651858.CD007667.pub3-BIB0147|cit147","volume-title":"Personality Disorders Over Time: Precursors, Course, and Outcome","author":"Paris","year":"2003"},{"issue":"6","key":"10.1002\/14651858.CD007667.pub3-BIB0148|cit148","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1","article-title":"Factor structure of the Barratt Impulsiveness Scale","volume":"51","author":"Patton","year":"1995","journal-title":"Journal of Clinical Psychology"},{"issue":"1","key":"10.1002\/14651858.CD007667.pub3-BIB0149|cit149","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1080\/10401230601163501","article-title":"A comparison of adults with antisocial personality traits with and without childhood conduct disorder","volume":"19","author":"Perdikouri","year":"2007","journal-title":"Annals of Clinical Psychiatry"},{"issue":"10","key":"10.1002\/14651858.CD007667.pub3-BIB0150|cit150","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/j.biopsych.2005.02.016","article-title":"Naltrexone and disulfiram in patients with alcohol dependence and comorbid psychiatric disorders","volume":"57","author":"Petrakis","year":"2005","journal-title":"Biological Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD007667.pub3-BIB0151|cit151","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1001\/archpsyc.57.2.119","article-title":"Reduced prefrontal gray matter volume and reduced autonomic activity in antisocial personality disorder","volume":"57","author":"Raine","year":"2000","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD007667.pub3-BIB0152|cit152","volume-title":"Report of the Department of Health and Home Office Working Group on Psychopathic Disorder (Chairman, Dr John Reed, CB)","author":"Department of Health","year":"1994"},{"key":"10.1002\/14651858.CD007667.pub3-BIB0153|cit153","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014"},{"issue":"9","key":"10.1002\/14651858.CD007667.pub3-BIB0154|cit154","doi-asserted-by":"publisher","first-page":"1257-88","DOI":"10.1017\/S1461145711000071","article-title":"Evidence-based pharmacotherapy for personality disorders","volume":"14","author":"Ripoll","year":"2011","journal-title":"International Journal of Neuropsychopharmacology"},{"issue":"8","key":"10.1002\/14651858.CD007667.pub3-BIB0155|cit155","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s001270050071","article-title":"The intimate connection between antisocial personality and substance abuse","volume":"33","author":"Robins","year":"1998","journal-title":"Social Psychiatry and Psychiatric Epidemiology"},{"issue":"5","key":"10.1002\/14651858.CD007667.pub3-BIB0156|cit156","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1002\/cbm.1866","article-title":"Cost implications of treatment non-completion in a forensic personality disorder service","volume":"23","author":"Sampson","year":"2013","journal-title":"Criminal Behaviour and Mental Health"},{"key":"10.1002\/14651858.CD007667.pub3-BIB0157|cit157","unstructured":"Sch\u00fcnemann H Bro\u017cek J Guyatt G Oxman A Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach (updated October 2013). GRADE Working Group, 2013 Available from gdt.guidelinedevelopment.org\/app\/handbook\/handbook.html"},{"issue":"7306","key":"10.1002\/14651858.CD007667.pub3-BIB0158|cit158","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1136\/bmj.323.7306.191","article-title":"Financial cost of social exclusion: follow up study of antisocial children into adulthood","volume":"323","author":"Scott","year":"2001","journal-title":"BMJ"},{"issue":"5289","key":"10.1002\/14651858.CD007667.pub3-BIB0159|cit159","doi-asserted-by":"publisher","first-page":"113-4","DOI":"10.1038\/230113a0","article-title":"Effect of lithium on human aggression","volume":"230","author":"Sheard","year":"1971","journal-title":"Nature"},{"issue":"12","key":"10.1002\/14651858.CD007667.pub3-BIB0160|cit160","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1176\/ajp.133.12.1409","article-title":"The effect of lithium on impulsive aggressive behavior in man","volume":"133","author":"Sheard","year":"1976","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD007667.pub3-BIB0161|cit161","volume-title":"Psychiatric Morbidity Among Prisoners in England and Wales","author":"Singleton","year":"1998"},{"issue":"12","key":"10.1002\/14651858.CD007667.pub3-BIB0162|cit162","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0006-3223(02)01325-2","article-title":"The borderline diagnosis II: biology, genetics and clinical course","volume":"51","author":"Skodol","year":"2002","journal-title":"Biological Psychiatry"},{"issue":"10","key":"10.1002\/14651858.CD007667.pub3-BIB0163|cit163","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1176\/appi.ajp.162.10.1919","article-title":"Dimensional representations of DSM-IV personality disorders: relationships to functional impairment","volume":"162","author":"Skodol","year":"2005","journal-title":"American Journal of Psychiatry"},{"issue":"7","key":"10.1002\/14651858.CD007667.pub3-BIB0164|cit164","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1176\/appi.ajp.2018.18040481","article-title":"Can Personality Disorders Be Redefined in Personality Trait Terms?","volume":"175","author":"Skodol Andrew","year":"2018","journal-title":"American Journal of Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD007667.pub3-BIB0165|cit165","first-page":"195","article-title":"Algorithms for pharmacological treatment of personality dimensions: symptom-specific treatments for cognitive-perceptual, affective, and impulsive-behavioral dysregulation","volume":"62","author":"Soloff","year":"1998","journal-title":"Bulletin of the Menninger Clinic"},{"key":"10.1002\/14651858.CD007667.pub3-BIB0166|cit166","volume-title":"STAXI-2: State-Trait Anger Expression Inventory-2: Professional Manual","author":"Spielberger","year":"1999"},{"issue":"2","key":"10.1002\/14651858.CD007667.pub3-BIB0167|cit167","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1192\/bjp.161.2.167","article-title":"Drug treatment of the personality disorders","volume":"161","author":"Stein","year":"1992","journal-title":"British Journal of Psychiatry"},{"issue":"11","key":"10.1002\/14651858.CD007667.pub3-BIB0168|cit168","first-page":"506","article-title":"An open trial of valproate in borderline personality disorder","volume":"56","author":"Stein","year":"1995","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD007667.pub3-BIB0169|cit169","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/2046-4053-3-54","article-title":"Study flow diagrams in Cochrane systematic review updates: an adapted PRISMA flow diagram","volume":"3","author":"Stovold","year":"2014","journal-title":"Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD007667.pub3-BIB0170|cit170","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1176\/jnp.2006.18.3.302","article-title":"Neurodevelopmental pathways to aggression: a model to understand and target treatment in youth","volume":"18","author":"Sugden","year":"2006","journal-title":"Journal of Neuropsychiatry and Clinical Neurosciences"},{"issue":"2","key":"10.1002\/14651858.CD007667.pub3-BIB0171|cit171","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1080\/09638230020023570-2","article-title":"A new scale (SES) to measure engagement with community mental health services","volume":"11","author":"Tait","year":"2002","journal-title":"Journal of Mental Health"},{"issue":"4","key":"10.1002\/14651858.CD007667.pub3-BIB0172|cit172","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1521\/pedi.2010.24.4.412","article-title":"Revised NESARC personality disorder diagnoses: gender, prevalence, and comorbidity with substance dependence disorders","volume":"24","author":"Trull","year":"2010","journal-title":"Journal of Personality Disorders"},{"issue":"5","key":"10.1002\/14651858.CD007667.pub3-BIB0173|cit173","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1192\/apt.10.5.389","article-title":"Drug treatment for personality disorders","volume":"10","author":"Tyrer","year":"2004","journal-title":"Advances in Psychiatric Treatment"},{"issue":"3","key":"10.1002\/14651858.CD007667.pub3-BIB0174|cit174","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1177\/0020764005057391","article-title":"The Social Functioning Questionniare: a rapid and robust measure of perceived functioning","volume":"51","author":"Tyrer","year":"2005","journal-title":"International Journal of Social Psychiatry"},{"issue":"9969","key":"10.1002\/14651858.CD007667.pub3-BIB0175|cit175","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S0140-6736(14)61995-4","article-title":"Classification, assessment, prevalence, and effect of personality disorder","volume":"385","author":"Tyrer","year":"2015","journal-title":"The Lancet"},{"issue":"6","key":"10.1002\/14651858.CD007667.pub3-BIB0176|cit176","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1192\/bjp.2018.202","article-title":"Prevalence of personality disorders in the general adult population in Western countries: systematic review and meta-analysis","volume":"213","author":"Volkert","year":"2018","journal-title":"British Journal of Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD007667.pub3-BIB0177|cit177","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jpsychires.2009.07.005","article-title":"Neuronal correlates and serotonergic modulation of behavioural inhibition and reward in healthy and antisocial individuals","volume":"44","author":"V\u00f6llm","year":"2010","journal-title":"Journal of Psychiatric Research"},{"key":"10.1002\/14651858.CD007667.pub3-BIB0178|cit178","volume-title":"Review of Treatments for Severe Personality Disorder","author":"Warren","year":"2001"},{"issue":"9","key":"10.1002\/14651858.CD007667.pub3-BIB0179|cit179","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1001\/archpsyc.1976.01770090101010","article-title":"Assessment of social adjustment by patient self-report","volume":"33","author":"Weissman","year":"1976","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD007667.pub3-BIB0180|cit180","first-page":"44","article-title":"The epidemiology of personality disorders: a 1990 update","volume":"Suppl 1","author":"Weissman","year":"1993","journal-title":"Journal of Personality Disorders"},{"issue":"1","key":"10.1002\/14651858.CD007667.pub3-BIB0181|cit181","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3109\/10401239509149022","article-title":"Divalproex sodium as a treatment for borderline personality disorder","volume":"7","author":"Wilcox","year":"1995","journal-title":"Annals of Clinical Psychiatry"},{"issue":"9","key":"10.1002\/14651858.CD007667.pub3-BIB0182|cit182","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1046\/j.1360-0443.1999.94912792.x","article-title":"A review of biological indicators of illicit drug use: practical considerations and clinical usefulness","volume":"94","author":"Wolff","year":"1999","journal-title":"Addiction"},{"issue":"6","key":"10.1002\/14651858.CD007667.pub3-BIB0183|cit183","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The Hospital Anxiety and Depression Scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"1","key":"10.1002\/14651858.CD007667.pub3-BIB0184|cit184","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007667","article-title":"Pharmacological interventions for antisocial personality disorder","author":"Khalifa","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"10.1002\/14651858.CD007667.pub3-BIB0185|cit185","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007667.pub2","article-title":"Pharmacological interventions for antisocial personality disorder","author":"Khalifa","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T04:19:10Z","timestamp":1677039550000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD007667.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Developmental, Psychosocial and Learning Problems Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,9,3]]},"references-count":185,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2020,9]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd007667.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,3]]}}}